MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Clinical trials for MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to boost transplant success in rare blood cancers
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) along with a JAK inhibitor (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPNs) get to transplant and have better outcomes. About 25 a…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
Hope for rare blood cancer: new combo trial targets tough cases
Disease control Recruiting nowThis study tests whether adding iadademstat to the standard drug ASTX727 works better than ASTX727 alone for people with advanced myeloproliferative neoplasms (MPNs), a group of rare blood cancers. About 62 adults whose disease has progressed to a more aggressive phase will be ra…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:54 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 05:48 UTC